Innovative Antipsychotic ADASUVE® to Benefit Even More Patients
Vienna, Austria, May 28, 2015 / B3C newswire / -- As an easy-to-use and highly reliable inhalation powder, the antipsychotic ADASUVE® has revolutionized the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder. This …